100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine
Salt Composition in bothYou Searched
Mirasmart 25 Tablet ER
RPG Life Sciences Ltd.
₹264.2
Our Recommendation
Miragron 25mg Tablet ER 10s
3,390+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
Used In
Treatment of Overactive bladder (OAB) symptoms
Customers also bought
More About Mirasmart
Benefits
In Treatment of Overactive bladder (OAB) symptoms Mirasmart 25 Tablet ER helps to treat uncontrollable contractions (spasms) of the bladder muscles that cause frequent urination, urgent need to urinate, and inability to control the passing of urine. It also relieves painful, or frequent urination and reduces the urgency to urinate that may occur with some infections of the urinary tract. This way it helps manage the overactive bladder symptoms efficiently.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Mirasmart 25 Tablet ER can be taken it with or without food, although it's advisable to take it consistently at the same time.
How it works
Mirasmart 25 Tablet ER is a beta 3-receptor agonist. It works by activating the receptor in the bladder, causing the bladder muscles to relax. It prevents frequent, urgent or uncontrolled urination.
Caution: It is important to consult your doctor regarding alcohol consumption while taking Mirasmart 25 Tablet ER .
Seek medical advice from your doctor: Mirasmart 25 Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Seek medical advice from your doctor: Mirasmart 25 Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
SAFE - Mirasmart 25 Tablet ER does not usually affect your ability to drive.
Caution Advised: Mirasmart 25 Tablet ER should be used with caution in patients with severe kidney disease. Dose adjustment of Mirasmart 25 Tablet ER may be needed. Doctor consultation is advised.
Caution Advised: Mirasmart 25 Tablet ER should be used with caution in patients with liver disease. Dose adjustment of Mirasmart 25 Tablet ER may be needed. Doctor consultation is advised. Use of Mirasmart 25 Tablet ER is not recommended in patients with severe liver disease.
Manufacturer Address
463, 4 th Floor, RPG HOUSE, Dr. Annie Besant Road, Worli, Mumbai ‚ 400 030. Maharashtra, INDIA
References
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 924-25
Medscape. Mirabegron (04 Apr. 2019)
Mirabegron. Chertsey, Surrey: Astellas Pharma Ltd.; 2012 (25 Jan. 2019)
Mirabegron. Norman, Oklahoma: Astellas Pharma Technologies, Inc; 2012 (04 Apr. 2019)
National Health Services. Mirabegron (11 Jul. 2023)
CiplaMed. Mirabegron (11 Jul. 2023)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
